Suppression of NF-κB Reduces Myocardial No-Reflow

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Zeng, Min ^a,c   Yan, Hongbing ^b   Chen, Yi ^a   Zhao, Han jun ^b   Lv, Yuan ^a   Liu, Cheng ^b   Zhou, Peng ^a   Zhao, Bo ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b FUWAI HOSPITAL   (China)

^c HAINAN PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL16 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; PYRROLIDINE DITHIOCARBAMATE; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; MALE; NEUTROPHIL CHEMOTAXIS; NO REFLOW PHENOMENON; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS INHIBITION; RABBIT; REPERFUSION INJURY; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; CELL LINE; CHEMOKINES, CXC; CORONARY VESSELS; HEART; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; MALE; MYOCARDIUM; NEUTROPHIL INFILTRATION; NF-KAPPA B; PROLINE; RABBITS; REPERFUSION INJURY; THIOCARBAMATES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84867301357     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047306     Document Type: Article

References (27)

1. Niccoli G, Burzotta F, Galiuto L, Crea F, (2009) Myocardial no-reflow in humans. J Am Coll Cardiol 54: 281-292.
2. Chan W, Stub D, Clark DJ, Ajani AE, Andrianopoulos N, et al. (2011) Usefulness of Transient and Persistent No Reflow to Predict Adverse Clinical Outcomes Following Percutaneous Coronary Intervention. Am J Cardiol.
3. Jaffe R, Charron T, Puley G, Dick A, Strauss BH, (2008) Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation 117: 3152-3156.
4. Kloner RA, Ganote CE, Jennings RB, (1974) The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54: 1496-1508.
5. Celik T, Iyisoy A, Yuksel UC, Jata B, Ozkan M (2009) The impact of admission C-reactive protein levels on the development of no-reflow phenomenon after primary PCI in patients with acute myocardial infarction: the role of inflammation. Int J Cardiol 136: 86-88; author reply 88-89.
6. Takahashi T, Hiasa Y, Ohara Y, Miyazaki S, Ogura R, et al. (2007) Relation between neutrophil counts on admission, microvascular injury, and left ventricular functional recovery in patients with an anterior wall first acute myocardial infarction treated with primary coronary angioplasty. Am J Cardiol 100: 35-40.
7. Venkatachalam K, Prabhu SD, Reddy VS, Boylston WH, Valente AJ, et al. (2009) Neutralization of interleukin-18 ameliorates ischemia/reperfusion-induced myocardial injury. J Biol Chem 284: 7853-7865.
8. Moss NC, Stansfield WE, Willis MS, Tang RH, Selzman CH, (2007) IKKbeta inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 293: H2248-2253.
9. Reffelmann T, Kloner RA, (2002) Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit. Am J Physiol Heart Circ Physiol 283: H1099-1107.
10. Zeng M, Kikuchi H, Pino MS, Chung DC, (2010) Hypoxia activates the K-ras proto-oncogene to stimulate angiogenesis and inhibit apoptosis in colon cancer cells. PLoS One 5: e10966.
11. Rezkalla SH, Kloner RA, (2008) Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory. Catheter Cardiovasc Interv 72: 950-957.
12. Ao L, Zou N, Cleveland JC Jr, Fullerton DA, Meng X, (2009) Myocardial TLR4 is a determinant of neutrophil infiltration after global myocardial ischemia: mediating KC and MCP-1 expression induced by extracellular HSC70. Am J Physiol Heart Circ Physiol 297: H21-28.
13. Yellon DM, Hausenloy DJ, (2007) Myocardial reperfusion injury. N Engl J Med 357: 1121-1135.
14. Litt MR, Jeremy RW, Weisman HF, Winkelstein JA, Becker LC, (1989) Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury. Circulation 80: 1816-1827.
15. Engler RL, Schmid-Schonbein GW, Pavelec RS, (1983) Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 111: 98-111.
16. Frantz S, Tillmanns J, Kuhlencordt PJ, Schmidt I, Adamek A, et al. (2007) Tissue-specific effects of the nuclear factor kappaB subunit p50 on myocardial ischemia-reperfusion injury. Am J Pathol 171: 507-512.
17. Vinten-Johansen J, (2004) Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 61: 481-497.
18. Gao X, Zhang H, Belmadani S, Wu J, Xu X, et al. (2008) Role of TNF-alpha-induced reactive oxygen species in endothelial dysfunction during reperfusion injury. Am J Physiol Heart Circ Physiol 295: H2242-2249.
19. Briaud SA, Ding ZM, Michael LH, Entman ML, Daniel S, et al. (2001) Leukocyte trafficking and myocardial reperfusion injury in ICAM-1/P-selectin-knockout mice. Am J Physiol Heart Circ Physiol 280: H60-67.
20. Fukushima S, Coppen SR, Varela-Carver A, Yamahara K, Sarathchandra P, et al. (2006) A novel strategy for myocardial protection by combined antibody therapy inhibiting both P-selectin and intercellular adhesion molecule-1 via retrograde intracoronary route. Circulation 114: I251-256.
21. Shimaoka T, Nakayama T, Fukumoto N, Kume N, Takahashi S, et al. (2004) Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells. J Leukoc Biol 75: 267-274.
22. Abel S, Hundhausen C, Mentlein R, Schulte A, Berkhout TA, et al. (2004) The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol 172: 6362-6372.
23. Ruth JH, Arendt MD, Amin MA, Ahmed S, Marotte H, et al. (2010) Expression and function of CXCL16 in a novel model of gout. Arthritis Rheum 62: 2536-2544.
24. Mitsuoka H, Toyohara M, Kume N, Hayashida K, Jinnai T, et al. (2009) Circulating soluble SR-PSOX/CXCL16 as a biomarker for acute coronary syndrome-comparison with high-sensitivity C-reactive protein. J Atheroscler Thromb 16: 586-593.
25. Stansfield WE, Moss NC, Willis MS, Tang R, Selzman CH, (2007) Proteasome inhibition attenuates infarct size and preserves cardiac function in a murine model of myocardial ischemia-reperfusion injury. Ann Thorac Surg 84: 120-125.
26. Fischer UM, Antonyan A, Bloch W, Mehlhorn U, (2006) Impact of antioxidative treatment on nuclear factor kappa-B regulation during myocardial ischemia-reperfusion. Interact Cardiovasc Thorac Surg 5: 531-535.
27. Gordon JW, Shaw JA, Kirshenbaum LA, (2011) Multiple facets of NF-kappaB in the heart: to be or not to NF-kappaB. Circ Res 108: 1122-1132.